Loading...

VAISHALI Vaishali Pharma Ltd Capital Structure Changes Announcement

Vshl

VSHL

Vaishali Pharma Ltd

(VAISHALI)

2026 Announcement

Price movement clarification

Regulatory Compliance

Regulatory compliance discl...

Regulatory disclosure under...

Trading Window Closure

Preferential issue of equit...

Postal Ballot Corrigendum

Newspaper publication for p...

Newspaper publication of re...

Preferential issue

Preferential Issue

Preferential issue

Preferential Issue

Associate acquisition

Regulatory Compliance

Preferential issue

Newspaper publication

Unaudited Results

Unaudited Financial Results

SEBI Certificate Submission

Trading Window Closure

Management Change

AGM Report Submitted

Annual General Meeting

Newspaper Publication

Annual General Meeting

Financial Results Published

Board Meeting Outcome

Board Meeting Outcome

SEBI Compliance Certificate

Trading Window Closure

Financial Results Publication

Financial Results Submitted

Board Meeting Outcome

Management Change

CFO Appointment

Disclosure Submitted

Management Change

AOA/MOA Amendment

Postal Ballot Results

SEBI Certificate Confirmation

Postal Ballot Notice

Postal Ballot Notice

Trading Window Closure

CFO Resignation

Stake Acquisition

Stake Acquisition

Financial Results Publication

No Fund Deviation

Integrated Filing

Quarterly Results

Board Meeting Outcome

New Independent Director

Director Appointment

Director Retirement

SEBI Compliance Confirmation

Investor Complaints Report

Director Resignation

Trading Window Closure

Financial Results Published

Financial Results Announced

Bonus Share Issue

Bonus Share Announcement

Financial Advisor Appointment

SEBI Compliance Cert.

Director Appointment

Board Meeting Outcomes

Record Date Set

AGM Voting Report

Trading Window Closure

AGM Proceedings

Growth Strategy

Bonus Issue & Split

Stock Split & Bonus

Bonus Share Announcement

Trading Window Closure

Book Closure Notice

Record Date Announcement

Q1 Financial Results

No Fund Deviation

Financial Results Released

Board Meeting Outcome

Global Registrations Secured

Equity Shares Allotment

Board Meeting Outcome

Compliance Certificate

Trading Window Closure

Equity Shares Conversion

Financial Results Published

Financial Results Submission

Conversion of Warrants

Disclosure Submission

Equity shares conversion

Compliance Certificate Subm...

Trading Window Closure

Earning Call Transcript

Audio Recording Link

Investor Presentation

Increased Revenue in Q3 FY24

Conference Call

Financial Results Publication

Financial Results Submission

Compliance Certificate

Board Meeting Outcome

Trading Window Closure

Analysts/Investors Meeting ...

Investor Presentation

Conference Call

Exhibition at CPHI Barcelona

Certificate Compliance

Proceedings Submission

Trading Window Closure

Revised Annual Report

Newspaper Advertisement

Book Closure for Meeting

External Links:

Data:

Vaishali Pharma reports Q3FY25 unaudited results and approves a preferential allotment of up to 61.23 lakh equity shares to non-promoter investors through share swap with Kesar Pharma, subject to approvals.

AI Assistant

Vaishali Pharma Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.